12 studies found for: Open Studies | "Hemorrhagic Fever, Ebola"
Clinical Trial of the cAd3-EBO and cAd3-EBOZ Ebola Vaccines in Healthy Adults in Uganda
A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
Efficacy of Favipiravir Against Ebola (JIKI)
Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
|7||Not yet recruiting||
Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)
|8||Not yet recruiting||
Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)
A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430
Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
† Indicates status has not been verified in more than two years